
CY 2026 OPPS/ASC Final Rule: Skin Substitute Payment Reform
Effective January 1, 2026, CMS finalized a major shift in how skin substitute products are paid under the OPPS, ASC, and non-facility settings, with coding,

Effective January 1, 2026, CMS finalized a major shift in how skin substitute products are paid under the OPPS, ASC, and non-facility settings, with coding,

CMS released the CY 2026 OPPS/ASC Final Rule, introducing significant updates to Hospital Price Transparency (HPT) standards that take effect January 1, 2026. These revisions

CMS has released the CY 2026 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Final Rule, confirming several major policy shifts while making notable changes to

The OIG’s recent audit of dermatology providers highlights a critical compliance checkpoint: billing of evaluation & management (E/M) services on the same day as minor

With the passage of H.R. 5371, the government shutdown has officially ended—and key Medicare telehealth flexibilities have been restored and extended through January 30, 2026. This extension closes the

The Centers for Medicare & Medicaid Services (CMS) has issued the CY 2026 Medicare PFS Final Rule (CMS-1832-F), and it brings major updates to payment policies under